Catalyst Wire Dossier Catalyst Wire Dossier

T-allo10 cell addback therapy (alpha-beta T-cell-depleted donor stem cells)

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for T-allo10 cell addback therapy (alpha-beta T-cell-depleted donor stem cells), covering 2026-01-08 to 2026-01-08. Get the full timeline:

Most recent: Clinical Trial Update: Stem Cell Transplant From Donors After Alpha Beta Cell Depletion in Children and Adults With T-allo10 Cells Addback [Phase 1]

See pricing